Primary Hyperparathyroidism: Clinical Trials

69 trials for Primary Hyperparathyroidism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

40 completed, 12 recruiting, 8 unknown, 3 not yet recruiting. 19 Not applicable, 8 Phase 2, 7 Phase 3, 6 Phase 4, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 16, Recruiting 2, Unknown 1
Phase 28Completed 4, Unknown 2, Recruiting 1, Withdrawn 1
Phase 37Completed 5, Recruiting 1, Withdrawn 1
Phase 46Completed 2, Recruiting 2, Terminated 1, Unknown 1
Phase 13Completed 3

Follow Primary Hyperparathyroidism: new trials by email Literature Review of Primary Hyperparathyroidism trials Research Report on Primary Hyperparathyroidism

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NIRAF-camera Versus Conventional Surgery in Preoperative Imaging Negative Primary Hyperparathyroidism
NIRAF-camera - Primary Hyperparathyroidism
Not applicableRecruitingThe Cleveland Clinic802026-08-312026-09-11
Shortwave Infrared Surgical Imaging Device Study
Observational study of SWIR imaging device in surgery - Cholecystitis, Cholecystitis, Chronic
Enrolling by invitationCision Vision, Inc.502026-05-292026-08-04
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
18F-FCH, NeuroEXPLORER - Primary Hyperparathyroidism, Parathyroid Cancer
Phase 2 / Phase 3RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1932026-04-162026-06-02
Aldosterone Variations in Patients With Primary Hyperparathyroidism After Surgery
Primary Hyperparathyroidism, Primary Hyperparathyroidism Due to Adenoma
Not yet recruitingCentral Hospital, Nancy, France4002026-02-012026-02-05
Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders
Osteoporosis, Hypercalcemia
RecruitingMartin Blomberg Jensen200002026-01-012026-09-17
Is Intraoperative PTH Monitoring Obsolete in Times of Choline PET/CT? a Prospective Multicenter Cohort Study to Determine Whether the Regular Preoperative Use of Choline-PET/CT Scan Obviate the Need for Intraoperative PTH-measurement in Patients with Primary Hyperparathyreoidism
Primary Hyperparathyroidism
Not yet recruitingUniversity of Zurich10002025-09-012025-02-03
Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism
Zoledronic acid 4 mg, Natriumklorid 9 mg/ml, Fresenius Kabi - Primary Hyperparathyroidism
Phase 4RecruitingUniversity of Aarhus1402025-03-012026-10-01
Diagnostic Performance of [11C]Choline PET/CT In the Preoperative Assessment of Primary Hyperparathyroidism
PET/CT - Primary Hyperparathyroidism
Not yet recruitingIRCCS San Raffaele2002025-01-012024-10-22
Upfront Ultrasound for Preoperative Localization in Primary Hyperparathyroidism
Primary Hyperparathyroidism
CompletedOdense University Hospital992023-09-012026-01-14
Parathyroid Tumor Clonal Status
Parathyroid Tumor, Primary Hyperparathyroidism
RecruitingWashington University School of Medicine8392023-07-282026-05-12
Glycemic Control, Type II Diabetes, Parathyroidectomy
Urine and Blood Test - Primary Hyperparathyroidism, Type 2 Diabetes
Active not recruitingThe Cleveland Clinic802023-02-272026-05-26
18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism
Parathyroidectomy - Primary Hyperparathyroidism
Not applicableRecruitingRegion Skane882023-01-012025-08-24
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Neuroendocrine Neoplasm, Neuroendocrine Neoplasm of Gastrointestinal Tract
RecruitingUniversidad Nacional Autonoma de Mexico7502022-08-032024-07-26
Object Assessment of Improvement in Non-Specific Symptoms After Parathyroidectomy for Primary Hyperparathyroidism
Activity Tracker (Fitbit), HbA1C, The PROMPT Questionnaire - Primary Hyperparathyroidism, Multinodular Goiter
CompletedThe Cleveland Clinic452022-07-192024-08-06
Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
PTeye, Standard of Care - Parathyroid Adenoma, Parathyroid Neoplasms
Not applicableCompletedUniversity of Michigan1602021-12-012025-08-27
Natural History Study of Parathyroid Disorders
Parathyroid Cancer, Primary Hyperparathyroidism
RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)30002021-11-302026-09-17
Gait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism
gait analysis - Primary Hyperparathyroidism
Not applicableCompletedRecep Tayyip Erdogan University Training and Research Hospital402021-10-172023-12-05
Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy
NIRAF Detection Technology - Parathyroid Adenoma, Parathyroid Neoplasms
Not applicableCompletedVanderbilt-Ingram Cancer Center1602020-03-132024-05-13
Preoperative Localization Strategies in Primary Hyperparathyroidism
Contrast-enhanced ultrasound - Primary Hyperparathyroidism
Not applicableCompletedOdense University Hospital1722019-09-052022-04-14
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
Calcitonin - Primary Hyperparathyroidism, Hypercalcemia
Phase 4RecruitingJoseph Sferra372019-05-292024-09-19

Showing 20 of 69. Sign in to see all of them.

Narrower conditions

Hyperparathyroidism, Primary (69)  ·  Parathyroid Neoplasms (13)  ·  Hypercalcemia (9)  ·  Bone Diseases, Metabolic (6)  ·  Osteoporosis (6)  ·  Hyperparathyroidism (5)  ·  Vitamin D Deficiency (4)  ·  Multiple Endocrine Neoplasia Type 1 (3)  ·  Thyroid Diseases (3)  ·  Osteoporosis, Postmenopausal (2)  ·  Parathyroid Diseases (2)  ·  Acromegaly (1)  ·  Adenoma, Islet Cell (1)  ·  Adrenal Gland Diseases (1)  ·  Atherosclerosis (1)

Broader conditions

Endocrine System Diseases (68)  ·  Parathyroid Diseases (67)  ·  Hyperparathyroidism (64)  ·  Metabolic Diseases (20)  ·  Nutritional and Metabolic Diseases (20)  ·  Neoplasms (15)  ·  Endocrine Gland Neoplasms (14)  ·  Neoplasms by Site (14)  ·  Head and Neck Neoplasms (13)  ·  Musculoskeletal Diseases (12)  ·  Bone Diseases (11)  ·  Calcium Metabolism Disorders (10)  ·  Water-Electrolyte Imbalance (9)  ·  Avitaminosis (4)  ·  Bone Diseases, Metabolic (4)

Interventions

Cinacalcet (6)  ·  Cholecalciferol (4)  ·  Parathyroidectomy (4)  ·  Denosumab (3)  ·  Vitamin D (3)  ·  Zoledronic Acid (2)  ·  Alendronate (1)  ·  Amiloride (1)  ·  Calcitonin (1)  ·  Calcium (1)  ·  Calcium Carbonate (1)  ·  Congresses as Topic (1)  ·  Eplerenone (1)  ·  Fitness Trackers (1)  ·  Gait Analysis (1)

Sponsors

Columbia University (5)  ·  The Cleveland Clinic (3)  ·  University of Aarhus (3)  ·  Amgen (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Central Hospital, Nancy, France (2)  ·  HaEmek Medical Center, Israel (2)  ·  Karolinska University Hospital (2)  ·  Kyowa Kirin Co., Ltd. (2)  ·  M.D. Anderson Cancer Center (2)  ·  Medical University of Vienna (2)  ·  Nantes University Hospital (2)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2)  ·  Odense University Hospital (2)  ·  Region Skane (2)

Countries

United States (23)  ·  Denmark (8)  ·  France (7)  ·  Sweden (5)  ·  Austria (2)  ·  Israel (2)  ·  Italy (2)  ·  Japan (2)  ·  Switzerland (2)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  India (1)  ·  Mexico (1)  ·  Norway (1)

Top investigators

Bruno Niederle, Prof., MD (2)  ·  Judy Jin, MD (2)  ·  Shonni J Silverberg, MD (2)  ·  Smita Jha, M.D. (2)  ·  Adrienne Brouwers, MD PhD (1)  ·  Anand Vaidya, MD MMSc (1)  ·  Anders Bergenfelz, MD, Ass Prof (1)  ·  Anders OJ Bergenfelz, MD, PhD (1)  ·  Arturo Chiti, MD (1)  ·  Carmen C Solorzano, MD, FACS (1)  ·  Constantin Ungureanu, MD (1)  ·  Don Wilson, MD, FRCPC (1)  ·  Donald W Anderson, MD, FRCSC (1)

Results publications

PMID 40668552, PMID 10898180, PMID 15663056, PMID 16540904, PMID 16785355, PMID 17071309, PMID 17216827, PMID 17284629, PMID 17879694, PMID 19160424, PMID 19351725, PMID 19950385, PMID 20035529, PMID 21044114, PMID 21679561, PMID 24026893, PMID 24115138, PMID 25414430, PMID 25636048, PMID 25975331, PMID 26031271, PMID 26435425, PMID 28522130, PMID 30860588, PMID 31595982, PMID 32333877, PMID 33585500, PMID 35018442, PMID 35138562, PMID 35436153, PMID 36917123, PMID 37052913, PMID 37284613, PMID 37288292, PMID 37339334, PMID 37597095, PMID 38174154, PMID 39189547, PMID 39946193, PMID 41486083, PMID 42484783, PMID 42620272, PMID 42817602

NIH funding

R01CA212147 (2), R01DK032333 (2), R01DK084986 (2), 2008 (1), 2016 (1), 2018 (1), 2023 (1), P30CA016672 (1), R01DK066329 (1)